Sparta Biomedical, a privately held medical device company targeting partial knee resurfacing, today announced the closing of an oversubscribed Series Seed round of financing to complete preclinical activities for IDE submission.

Sparta's mission is to empower orthopedic surgeons with advancements that fundamentally restore movement for their patients. More information at www.sparta-biomedical.com
SOURCE Sparta Biomedical

Sparta Biomedical Raises $5M In Series Seed Financing To Advance Its Breakthrough Device For Partial Knee Resurfacing

Description

Company Information

Sparta Biomedical Raises $5M In Series Seed Financing To Advance Its Breakthrough Device For Partial Knee Resurfacing

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information